Home » Authors » Jim Shrine

Articles by Jim Shrine

Cephalon Acquiring Approved Muscle Relaxant For $100M

Aug. 24, 2007

Cephalon Acquiring Approved Muscle Relaxant For $100M

Aug. 24, 2007

Nuvelo Restarts Testing With Higher Dose Of Alfimerprase

Aug. 23, 2007

Nuvelo Restarts Testing With Higher Dose Of Alfimerprase

Aug. 23, 2007

Oncoscience Starts Phase III Trials Of YM's Nimotuzumab

Aug. 22, 2007

Oncoscience Starts Phase III Trials Of YM's Nimotuzumab

Aug. 22, 2007

Insys Registers For IPO To Fund Cannabinoid, Fentanyl Products

Aug. 21, 2007

Insys Registers For IPO To Fund Cannabinoid, Fentanyl Products

Aug. 21, 2007

Cephalon Planning sNDA Filing Of Fentora In Breakthrough Pain

Aug. 17, 2007

Cephalon Planning sNDA Filing Of Fentora In Breakthrough Pain

Aug. 17, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...